HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation.

Abstract
In vivo imaging of apoptosis in a preclinical setting in anticancer drug development could provide remarkable advantages in terms of translational medicine. So far, several imaging technologies with different probes have been used to achieve this goal. Here we describe a bioluminescence imaging approach that uses a new formulation of Z-DEVD-aminoluciferin, a caspase 3/7 substrate, to monitor in vivo apoptosis in tumor cells engineered to express luciferase. Upon apoptosis induction, Z-DEVD-aminoluciferin is cleaved by caspase 3/7 releasing aminoluciferin that is now free to react with luciferase generating measurable light. Thus, the activation of caspase 3/7 can be measured by quantifying the bioluminescent signal. Using this approach, we have been able to monitor caspase-3 activation and subsequent apoptosis induction after camptothecin and temozolomide treatment on xenograft mouse models of colon cancer and glioblastoma, respectively. Treated mice showed more than 2-fold induction of Z-DEVD-aminoluciferin luminescent signal when compared to the untreated group. Combining D: -luciferin that measures the total tumor burden, with Z-DEVD-aminoluciferin that assesses apoptosis induction via caspase activation, we confirmed that it is possible to follow non-invasively tumor growth inhibition and induction of apoptosis after treatment in the same animal over time. Moreover, here we have proved that following early apoptosis induction by caspase 3 activation is a good biomarker that accurately predicts tumor growth inhibition by anti-cancer drugs in engineered colon cancer and glioblastoma cell lines and in their respective mouse xenograft models.
AuthorsMatteo Scabini, Fabio Stellari, Paolo Cappella, Sara Rizzitano, Gemma Texido, Enrico Pesenti
JournalApoptosis : an international journal on programmed cell death (Apoptosis) Vol. 16 Issue 2 Pg. 198-207 (Feb 2011) ISSN: 1573-675X [Electronic] Netherlands
PMID21082356 (Publication Type: Journal Article)
Chemical References
  • Luminescent Proteins
  • Oligopeptides
  • benzyloxycarbonyl-aspartyl-glutamyl-valyl-aspartyl-aminoluciferin
  • Firefly Luciferin
  • Dacarbazine
  • Caspase 3
  • Caspase 7
  • Camptothecin
  • Temozolomide
Topics
  • Animals
  • Apoptosis
  • Blotting, Western
  • Camptothecin (pharmacology)
  • Caspase 3 (metabolism)
  • Caspase 7 (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Colonic Neoplasms (drug therapy, enzymology, pathology)
  • Dacarbazine (analogs & derivatives, pharmacology)
  • Enzyme Activation
  • Firefly Luciferin (analogs & derivatives, chemistry, metabolism)
  • Flow Cytometry
  • Glioblastoma (drug therapy, enzymology, pathology)
  • Humans
  • Luminescent Measurements (methods)
  • Luminescent Proteins (chemistry, metabolism)
  • Mice
  • Mice, Nude
  • Oligopeptides (chemistry, metabolism)
  • Staining and Labeling
  • Temozolomide
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: